1. Immunomodulatory Effects of Halichondrin Isolated from Marine Sponges and Its Synthetic Analogs in Oncological Applications.
- Author
-
Dissanayake DS, Nagahawatta DP, Lee JS, and Jeon YJ
- Subjects
- Animals, Humans, Neoplasms drug therapy, Biological Products pharmacology, Biological Products chemistry, Furans pharmacology, Furans chemistry, Furans isolation & purification, Aquatic Organisms, Ketones pharmacology, Ketones chemistry, Ketones isolation & purification, Immunologic Factors pharmacology, Immunologic Factors chemistry, Immunologic Factors isolation & purification, Immunomodulating Agents pharmacology, Immunomodulating Agents chemistry, Immunomodulating Agents isolation & purification, Macrolides pharmacology, Macrolides chemistry, Polyether Polyketides, Ethers, Cyclic, Porifera chemistry, Antineoplastic Agents pharmacology, Antineoplastic Agents chemistry
- Abstract
Marine natural products comprise unique chemical structures and vast varieties of biological activities. This review aims to summarize halichondrin, a marine natural product, and its synthetic analogs along with its therapeutic properties and mechanisms. Halichondrin and its analogs, derived from marine sponges, exhibit potent antineoplastic properties, making them promising candidates for cancer therapeutics. These compounds, characterized by their complex molecular structures, have demonstrated significant efficacy in inhibiting microtubule dynamics, leading to cell cycle arrest and apoptosis in various cancer cell lines. Several types of halichondrins such as halichondrins B, C, norhalichondrin B, and homohalichondrin B have been discovered with similar anticancer and antitumor characteristics. Since naturally available halichondrins show hurdles in synthesis, recent advancements in synthetic methodologies have enabled the development of several halichondrin analogs, such as E7389 (eribulin), which have shown improved therapeutic indices. Eribulin has shown excellent immunomodulatory properties by several mechanisms such as reprogramming tumor microenvironments, facilitating the infiltration and activation of immune cells, and inhibiting microtubule dynamics. Despite promising results, challenges remain in the synthesis and clinical application of these compounds. This review explores the mechanisms underlying the immunomodulatory activity of halichondrin and its analogs in cancer therapy, along with their clinical applications and potential for future drug development.
- Published
- 2024
- Full Text
- View/download PDF